pentrinitrol has been researched along with carbon monoxide in 2 studies
*Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed) [MeSH]
*Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed) [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abate, A; Dennery, PA; Grosser, N; Hemmerle, A; Oberle, S; Schneider, HT; Schröder, H; Stalleicken, D; Vreman, HJ | 1 |
Grosser, N; Schröder, H | 1 |
2 other study(ies) available for pentrinitrol and carbon monoxide
Article | Year |
---|---|
Endothelial protection by pentaerithrityl trinitrate: bilirubin and carbon monoxide as possible mediators.
Topics: Animals; Antioxidants; Bilirubin; Carbon Monoxide; Cell Survival; Cells, Cultured; Endothelium, Vascular; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Isosorbide Dinitrate; Membrane Proteins; Nitric Oxide Donors; Pentaerythritol Tetranitrate; S-Nitroso-N-Acetylpenicillamine | 2003 |
[Therapy with NO donors-antiatherogenic and antioxidant actions].
Topics: Animals; Antioxidants; Arteriosclerosis; Carbon Monoxide; Clinical Trials as Topic; Coronary Artery Disease; Endothelium, Vascular; Enzyme Induction; Ferritins; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Membrane Proteins; Nitric Oxide Donors; Oxidative Stress; Pentaerythritol Tetranitrate; Rabbits; Vasodilator Agents | 2004 |